[go: up one dir, main page]

Tullis et al., 2002 - Google Patents

Affinity hemodialysis for antiviral therapy with specific application to HIV

Tullis et al., 2002

View PDF
Document ID
3953646080723406051
Author
Tullis R
Scamurra D
Ambrus Jr J
Publication year
Publication venue
Computational and Mathematical Methods in Medicine

External Links

Snippet

We propose an artificial lymph node to improve immune function in fighting viral diseases. The device is based on hemodialysis using a cartridge containing a solid phase affinity resin. Virus capture is mediated by a collection of broad specificity antibodies covalently …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits by absorption

Similar Documents

Publication Publication Date Title
US20210369933A1 (en) Method for removal of viruses from blood by lectin affinity hemodialysis
CA2342203C (en) Method for removal of hiv and other viruses from blood
US20110218512A1 (en) Enhanced antiviral therapy methods and devices
Caramelo et al. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid
Troccoli et al. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration
US20160000987A1 (en) Device and method for purifying virally infected blood
US20130023849A1 (en) Methods and systems for reducing viral load of hepatitis c virus in hemodialysis patients
Rivera et al. Pathophysiology of Ebola virus infection: current challenges and future hopes
Tullis et al. Affinity hemodialysis for antiviral therapy. I. Removal of HIV‐1 from cell culture supernatants, plasma, and blood
Tullis et al. Affinity hemodialysis for antiviral therapy with specific application to HIV
Terpstra et al. Viral safety of Nanogam®, a new 15 nm‐filtered liquid immunoglobulin product
Van Holten et al. Incorporation of an additional viral‐clearance step into a human immunoglobulin manufacturing process
Kim et al. Improvement of virus safety of an antihemophilc factor IX by virus filtration process
Koenderman et al. Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step
CN106267412A (en) Acquired immune deficiency syndrome (AIDS) immunologic purging instrument
HK1118077A (en) Method for removal of viruses from blood by lectin affinity hemodialysis
Willkommen 1d Virus transmission by virus-inactivated plasma products
Kagan Ebola hemorrhagic fever: a paradigm of multiorgan dysfunction
Terpstra Viral safety of blood and plasma products
Dimitrov Treatment of Crimean-Congo hemorrhagic fever 261
McNally et al. Intranasal Administration of dsRNA Analog Poly (I: C) Induces Interferon-a Receptor
Roychoudhury Convalescent Plasma Therapy: Solution to COVID-19